• In this June 14, 2011 file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. A safeguard for Medicare beneficiaries has become a way for drugmakers to get paid billions of dollars for pricey medications at taxpayer expense, government numbers show. The cost of Medicare’s “catastrophic” prescription coverage jumped by 85 percent in three years, from $27.7 billion in 2013 to $51.3 billion in 2015, according to the program’s number-crunching Office of the Actuary.  (AP Photo/Matt Rourke, File)

    AP Exclusive: Medicare safeguard overwhelmed by pricey drugs

    WASHINGTON (AP) — A safeguard for Medicare beneficiaries has become a way for drugmakers to get paid billions of dollars for pricey medications at taxpayer expense, government numbers show.

  • In this Thursday, Oct. 8, 2015 file photo, International Monetary Fund chief Christine Lagarde listens to a journalist during a press conference in Lima, Peru. France’s top court ruled on Friday July 22, 2016, that International Monetary Fund chief Christine Lagarde must stand trial in France over a 2008 arbitration ruling handing 400 million euros to a politically-connected business magnate. (AP Photo/Rodrigo Abd, File)

    IMF chief Lagarde to stand trial in French arbitration deal

    PARIS (AP) — France’s top court has ruled that International Monetary Fund chief Christine Lagarde must stand trial in France over a 2008 arbitration ruling that handed 400 million euros to a politically-connected business magnate.

  • People walk past an electronic stock indicator of a securities firm in Tokyo, Thursday, July 21, 2016. Asian shares were higher Thursday as Japan's benchmark rose on hopes of Japanese government stimulus spending and better-than-expected earnings lifted Wall Street. (AP Photo/Shizuo Kambayashi)

    Asian shares down as central banks wait and see

    LONDON (AP) — Stock markets turned higher on Friday after surveys suggested the eurozone economy is proving resilient to the uncertainty surrounding Britain’s Brexit vote. A big drop in business activity in the U.K. raised expectations of more central bank stimulus there.